MSX2 overexpression inhibits gemcitabine-induced caspase-3 activity in pancreatic cancer cells

Shin Hamada, Kennichi Satoh, Kenji Kimura, Atsushi Kanno, Atsushi Masamune, Tooru Shimosegawa

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


Aim: To evaluate the effect of MSX2 on gemcitabine-induced caspase-3 activation in pancreatic cancer cell line Panc-1. Methods: Using V5-tagged MSX2 expression vector, stable transfectant of MSX2 was generated from Panc-1 cells (P×14 cells). Cell viability under gemcitabine administration was determined by MTT assay relative to control cell line (empty-vector transfected Panc-1 cells; P-3EV cells). Hoechst staining was used for the detection of apoptotic cell. Activation of caspase-3 was assessed using Western blotting analysis and direct measurement of caspase-3 specific activities. Results: MSX2 overexpression in Panc-1 cells resulted in decreased gemcitabine-induced caspase-3 activation and increased cell viability under gemcitabine treatment in P×14 cells. Conclusion: MSX2 exerts repressive effects on gemcitabine-induced apoptotic pathway. This novel apoptosis-regulating function of MSX2 may provide a new therapeutic target for pancreatic cancer.

Original languageEnglish
Pages (from-to)6867-6870
Number of pages4
JournalWorld Journal of Gastroenterology
Issue number43
Publication statusPublished - 2005 Nov 21


  • Gemcitabine
  • MSX2Caspase-3


Dive into the research topics of 'MSX2 overexpression inhibits gemcitabine-induced caspase-3 activity in pancreatic cancer cells'. Together they form a unique fingerprint.

Cite this